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Background: Most people who stop smoking successfully for a few weeks will return to smoking again in the
medium term. There are few effective interventions to prevent this relapse and none used routinely in clinical
practice. A previous exploratory meta-analysis suggested that self-help booklets may be effective but requires
confirmation. This trial aims to evaluate the effectiveness and cost-effectiveness of a set of self-help educational
materials to prevent smoking relapse in the National Health Service (NHS) Stop Smoking Service.
Methods/design: This is an open, randomized controlled trial. The target population is carbon monoxide (CO)
verified quitters at four weeks in the NHS stop smoking clinic (total sample size N = 1,400). The experimental
intervention tested is a set of eight revised Forever Free booklets, including an introduction booklet and more
extensive information on all important issues for relapse prevention. The control intervention is a leaflet that has no
evidence to suggest it is effective but is currently given to some patients using NHS stop smoking services.
Two follow-up telephone interviews will be conducted at three and 12 months after the quit date. The primary
outcome will be prolonged abstinence from months four to 12 with no more than five lapses, confirmed by a CO
test at the 12-month assessment. The secondary outcomes will be seven-day self-report point prevalence
abstinence at three months and seven-day biochemically confirmed point prevalence abstinence at 12 months. To
assess cost-effectiveness, costs will be estimated from a health service perspective and the EQ-5D will be used to
estimate the QALY (Quality Adjusted Life Year) gain associated with each intervention.
The comparison of smoking abstinence rates (and any other binary outcomes) between the two trial arms will be
carried out using odds ratio as the outcome statistic and other related statistical tests. Exploratory subgroup
analyses, including logistic regression analyses with interaction terms, will be conducted to investigate possible
effect-modifying variables.
Discussion: The possible effect of self-help educational materials for the prevention of smoking relapse has
important public health implications.
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Behavioral support and pharmacotherapy are effective to
help smokers who are motivated to quit to do so [1-5].
However, relapse rates following these interventions are
high [6]. According to data from English Stop Smoking
Services, about 50% of smokers who set a quit date
stopped smoking at four weeks [7], but 75% of the four-
week quitters go back to regular smoking between four
and 52 weeks [8]. The long-term success rates still make
these interventions highly cost-effective but there is a
need to find effective interventions to reduce relapse
rates after the initial treatment episode. A Cochrane sys-
tematic review of trials of interventions for smoking
relapse prevention [9,10] concluded that ‘there is insuffi-
cient evidence to support the use of any specific inter-
vention for helping smokers who have successfully quit
for a short time to avoid relapse’ [11]. Therefore, the
current smoking cessation guidelines do not recommend
any specific interventions for smoking relapse preven-
tion [12,13]. A survey of smoking cessation professionals
found that the uncertain evidence base about effective-
ness was an important barrier to the use of relapse
prevention interventions [14].
Findings from systematic reviews
Psycho-educational interventions for smoking relapse
prevention are complex healthcare interventions that
usually contain several interacting components and in-
volve changes of people’s behaviors [15,16]. The new
Medical Research Council (MRC) guidance on develop-
ment and evaluation of complex interventions in health
stresses that ‘a good theoretical understanding is needed
of how the intervention causes change’ [16]. Pawson et
al. recommended a method of ‘realist review’, which
emphasizes the explicit consideration of theories under-
lying complex interventions [17]. We conducted a
theory-guided research synthesis of 49 trials on psycho-
educational interventions for smoking relapse prevention
in an updated systematic review [18,19]. Most interven-
tions in the trials included were at least partly based
on the cognitive-behavioral approach to coping skills
training [20].
With coping skills training, participants are trained to
identify situations with high risks of smoking relapse
(such as going out with friends or feeling frustrated) and
to develop and practice skills to cope with such situa-
tions. Therefore, the effectiveness of coping skills train-
ing for relapse prevention will depend on (1) the
delivery and receipt of interventions, (2) the acquisition
of coping skills by quitters and (3) the use of such skills
in high risk situations. This delineation of the mechan-
isms whereby coping skills training interventions work
suggests that the following mediating process is likely to
be important: acquisition of skills to identify and copewith high-risk situations and the actual use of coping
skills when required. However, only a few trials have
reported on these processes [19]. For example, only two
trials reported the actual use of coping skills by partici-
pants. They showed that those participants in skills
training and abstainers may be more likely to have used
their newly acquired coping skills than those who
relapsed [21,22].
The effectiveness of coping skills training differs be-
tween population subgroups. Our meta-analysis found
that coping skills training for smoking relapse preven-
tion was ineffective for pregnant or postpartum quitters,
hospitalized ex-smokers, forced short-term quitters, and
smokers with mental health illnesses or drug abusers.
For quitters from general communities, coping skills
training interventions were not effective for current
smokers who were motivated to quit (odds ratio (OR) =
0.96, 95% confidence interval (CI) 0.82 to 1.12) or for
those who had quit smoking for less than one week
(OR= 1.09, 95% CI 0.88 to 1.36). However, coping skills
training interventions significantly reduced smoking re-
lapse in community quitters who, at baseline, had been
able to quit for at least one week (OR= 1.44, 95% CI
1.14 to 1.81) [19].
These findings show that the timing of relapse preven-
tion is important and that coping skills training seems
effective in secured quitters who are highly motivated to
remain abstinent. Clearly, the acquisition of coping skills
alone is not sufficient and only those who use these
skills really benefit [23]. This evidence can be interpreted
in terms of the theoretical mechanisms of coping skills
training for relapse prevention.
Furthermore, interventions of using self-help materials
seem as effective as interventions based on individual or
group counseling. Five trials of coping skills training in
community quitters who stopped smoking for at least
one week were further separated into two subgroups:
trials of self-help material and trials of counseling. The
pooled OR of coping skills training is 1.46 (95% CI: 1.05
to 2.05) for self-help material trials and 1.41 (95% CI
1.02 to 1.94) for counseling trials [19]. A more recently
published meta-analysis also found that written self-
help materials were the only type of relapse preven-
tion intervention for unaided quitters with established
efficacy [24].
Forever free booklets
Self-guided educational materials for skills training seem
as effective as, but cheaper than, more expensive face-
to-face counseling sessions and so seem likely to be
more cost-effective. Brandon et al. have developed a
series of eight booklets to be used as self-help materials
for smoking relapse prevention [25,26]. Forever Free
booklets for smoking relapse prevention have been
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trolled trials in the United States [25,26] (included in the
meta-analysis above). Volunteers who had quit smoking
unaided were randomized to receive either all eight
booklets or only the introductory booklet. Participants
who received all eight booklets had a lower rate of
smoking relapse than participants who received only a
single booklet (the introduction booklet). The more re-
cent trial suggested that repeated mailing (high contact)
was no more effective than massed mailing (low contact)
of the eight booklets [26]. Brandon et al. suggested that
their two studies may have under-estimated the true ef-
fectiveness of Forever Free booklets, because partici-
pants in the control group received the introduction
booklet that provided a summary of all relevant skills.
The use of the Forever Free booklets for smoking relapse
prevention was likely to be highly cost-effective (US $83
to $160 per QALY gained) [26].
Objectives
Existing trials on coping skills training for smoking re-
lapse prevention in community quitters were mostly
conducted in the United States and recruited partici-
pants mainly by advertisement in newspapers. It is
uncertain whether the results of our meta-analysis [19]
and individual trials by Brandon et al. [25,26] are
generalizable to four-week quitters who used the NHS
stop smoking services. A more recently completed re-
port of health technology assessment also recommended
further research on the effectiveness of self-help inter-
ventions for smoking relapse prevention [27].
The current study aims to evaluate the effectiveness
and cost-effectiveness of self-help materials (Forever
Free booklets) for the prevention of smoking relapse in
four-week quitters who have used NHS stop smoking
services. By the end of the proposed trial, we will know
whether short-term quitters who have used self-help ma-
terial (Forever Free booklets) for relapse prevention have
a lower rate of smoking relapse at 12 months, as com-
pared with short-term quitters in the control group.
Methods/design
This is an open, randomized controlled trial to evaluate
the effectiveness of self-help educational materials
(Forever Free booklets) for the prevention of smoking
relapse, compared to a smoking cessation booklet used
currently. Figure 1 shows the flow diagram of the trial.
This will be an open trial, without attempts to blind
investigators and patients after randomization. Because
the outcome assessor and trial participants know the
allocated intervention, bias may be introduced into the
results. However, evidence suggests that the risk of bias
may be much reduced in trials with objectively assessed
outcomes [28]. In this proposed trial, the primaryoutcome will be biochemically verified smoking abstin-
ence at 12 months, which can be considered as an ob-
jectively assessed outcome.
Setting
We will recruit four-week quitters in NHS Stop Smoking
clinics (SmokeFree Norfolk, Norfolk Community Health
& Care). In comparison with the rest of England, Nor-
folk has a relatively high proportion of people aged 65
and above (21.4% versus 16.5% in 2010), and a higher
proportion of white people (94.3% versus 87.5% in
2009). Of those who set a quit date in 2010/2011, the
percentage of successful quitters was 52% as compared
with an average of 49% in England [29].
The investigated self-help educational materials will be
sent to trial participants for their use at home. At the
final follow-up (12 months from quit date), we will invite
those who are still not smoking to have a breath CO test
to confirm the self reported status of non-smoking. The
test will be carried out by a researcher from University
of East Anglia (UEA) in Norwich. People may come to a
clinic at UEA or we can visit them at home for this test.
Participant recruitment and randomization
Current smokers are referred to the NHS Stop Smoking
Clinics from various sources (for example, general prac-
titioners (GPs), self-referral, and so on). Clients who
contact the Stop Smoking Service are given an appoint-
ment for assessment with a stop smoking advisor, either
individually or in group sessions. Following assessment,
the client typically receives weekly behavioral support,
focused on withdrawal oriented therapy, with medica-
tion to reduce craving and withdrawal. The total con-
tact time for each client is at least 1.5 hours from pre-
quit preparation to four weeks after quitting. About
50% of clients who set a quit date are successful at four
weeks but most (75%) of them relapse by 12 months
[8]. Interventions for smoking relapse or maintenance
of abstinence are not routinely provided, although stop
smoking services will support renewed quit attempts
for relapsed smokers.
The target population of the proposed trial is four-
week quitters treated in the NHS Stop Smoking Service
clinics. Stop smoking advisors will give a Patient Infor-
mation Sheet to all expected quitters at week two or
three following the quit date. At the final follow-up ses-
sion (four weeks post-quit) in the NHS Stop Smoking
Service clinic, the advisor will again explain the nature
of the trial, to CO-verified quitters only, answer ques-
tions from them, and invite them to participate in the
trial by signing the consent form. Clients who have failed
to quit will not be included.
After eligible quitters have signed the consent form,
stop smoking advisors will help them complete the
Motivated smokers treated at the NHS Stop Smoking Clinics  
Session 1: Stop Smoking Advisors give Study Patient Information Sheet 
                 to all people who attend the clinic  
4 week after quit session: Stop Smoking Advisors discuss study with all CO-validated 
quitters and invite them to participate and sign the Consent Form 
Trial participants: Quitters who meet the inclusion criteria, sign the Consent Form
Random allocation
Control Group:  A letter and the Control 
leaflet will be mailed to participants by the 
researcher 
Intervention Group: A letter and the 
Forever Free booklets will be mailed to 
participants by the researcher 
Telephone follow-up at 3 mths by researcher: 
(will be posted if unable to contact by phone) 
• Smoking status 
• Process variables 
• Use of Stop Smoking & NHS services 
Telephone follow-up at 3 mths by researcher:
(will be posted if unable to contact by phone) 
• Smoking status 
• Process variables 
• Use of Stop Smoking & NHS services
Telephone follow-up at 12 mths by researcher:
• Same as 3 months 
Telephone follow-up at 12 mths by researcher: 
• Same as 3 months 
CO-validation of self-reported quitters at 12 
months at UEA CTU 
CO-validation of self-reported quitters at 12 
months at UEA CTU 
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with the Stop Smoking Advisor and complete the Baseline Questionnaire  
Figure 1 Flow Diagram – trial of self-help educational material (Forever Free booklets) for smoking relapse prevention.
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ator at UEA. The trial coordinator will randomly allocate
participants to two groups (the control group and the
relapse prevention group) and send them the corre-
sponding self-help material by post. Quitters in the con-
trol group will receive a letter and the currently used
leaflet, ‘Learning to Stay Stopped’. Quitters in the inter-
vention group will receive a letter and all eight Forever
Free booklets (see section Planned interventions for
more details on these booklets).
The random allocation of participants into the two
arms will be carried out by using a computerized alloca-
tion system provided by the Norwich Clinical Research
and Trial Unit (CRTU). This allocation of trial partici-
pants is ‘concealed’ because the recruitment of quitters
occurs before the random allocation.
It is necessary to avoid possible information contamin-
ation across the trial arms and ‘non-independence’ be-
tween members of the same family who live at the same
address. We will include only one member from thesame family in the analysis. Where couples of the same
family are recruited at the same time, we will randomly
select only one of them into the trial. If the members of
the same family use the NHS Stop Smoking Service at
different times during the trial recruitment period, we
will include only the first family member. To carry out
exploratory analysis, we will record information on
whether there are other family members who are
excluded for this reason.
We will prevent multiple entries of the same people
who make repeat attempts to quit during the trial
period. Before recruiting a new short-term quitter, stop
smoking advisors will check whether the quitter has
already been included in the trial. In addition, the trial
coordinator will also check to make sure no multiple en-
tries exist for the same quitter.
Planned interventions
The experimental intervention tested in the proposed
trial is the full pack of eight Forever Free booklets.
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cluding an introduction of nicotine dependence, the
stages of smoking cessation, situations that are high risk
for relapse, ways of coping with urges to smoke, the ab-
stinence violation effect, and ways to handle an initial
slip [26]. The remaining seven booklets provide more
extensive information on important issues for relapse
prevention and are entitled Smoking Urges; Smoking and
Weight; What if You Have a Cigarette?; Your Health;
Smoking, Stress, and Mood; Lifestyle Balance; and Life
Without Cigarettes [26]. The booklets can be understood
by people with a reading level of fifth to sixth grade in
the United States (expected reading level for children of
ten to 12 years old).
The original Forever Free Booklets are prepared for
users in the United States. We will revise and update
the booklets in places where judged necessary or help-
ful, to make the material more suitable to British users
and the UK NHS. We have obtained permission from
the copyright holders (H. Lee Moffitt Cancer Center
and Research Institute, Tampa, FL). Members of the
trial steering committee, project team, and three lay
representatives will review and comment on the
revised booklets.
During their modification, we will ensure the accept-
ability/understanding of the booklets to as wide a range
of users as possible. For the proposed trial, the revised
booklets will be available in the English language only
because of the considerable cost implications to translate
the booklets into other languages. If proved effective, the
booklets can be translated into other languages or differ-
ent media formats (for example, DVD video) for people
who have difficulty in English reading. For participant
recruitment, stop smoking advisors will find out whether
the client is able to read and understand English.
After randomization, we will send a letter and the full
pack of eight revised Forever Free booklets to partici-
pants in the intervention group and a currently used
leaflet (‘Learning to Stay Stopped’) to participants in the
control group. The leaflet (with eight pages in total) used
in the control contains comprehensive but brief informa-
tion on issues related to smoking relapse and provides
brief recommendations on how to cope with cravings
and tempting triggers.
Inclusion and exclusion criteria
The target population of the proposed trial is four-week
quitters treated in the NHS Stop Smoking Service
clinics. The biochemically verified four-week quitter is
defined as a treated smoker who reports abstinence from
day 14 post-quit date to the four-week follow-up point
(or within 25 to 42 days of the quit date) and who blows
an exhaled CO reading of less than 10 ppm [30]. The in-
clusion and exclusion criteria are summarized below.Inclusion criteria:
 CO-verified quitters at four weeks in the NHS Stop
Smoking Service clinic who sign the consent form
to participate in the trial.
Exclusion criteria:
 Pregnant quitters will be excluded. The process of
relapse in pregnant women is very different than
that in non-pregnant smokers. According to the
available research evidence [19], smoking relapse
prevention intervention by coping skills training is
ineffective for women who have stopped smoking
during pregnancy.
 We will exclude quitters who are not able to read
the educational material in English, because the
revised booklets are currently available in English
language only.
 We will exclude quitters from families at the same
address, as a family member has already been
included in the trial.
Sample size
The abstinence rate of four-week quitters at 12 months
is estimated to be 25.0% in the control and 32.4% in the
intervention group (based on an OR of 1.44). Assuming
alpha = 0.05 and 1-beta = 0.8 and a dropout rate of 15%,
about 1,400 patients will be required in total (700 in
each arm) [31]. To simplify the project management, we
will recruit participants mainly from the core Stop
Smoking clinics in Norfolk.
Baseline and follow up data collection
At the four-week session following the quit date, stop
smoking advisors will gather baseline information from
participants who have consented to be in the trial. The
information collected includes participants’ demographic
characteristics (for example, age, gender, and occupa-
tion), heaviness of smoking index, smoking and quitting
history, and level of confidence to remain abstinent.
The consensus statement of the Society for Research
on Nicotine and Tobacco (SRNT) and the Russell Stand-
ard both suggest that prolonged abstinence should be
the primary outcome of a smoking cessation trial
[32,33]. The normal form of prolonged abstinence allows
a two week grace period in which lapses do not invali-
date abstinence following quit day to assess the outcome
of aid to cessation trials. However, a relapse prevention
intervention might reasonably prevent lapses (occasional
smoking) from becoming relapses (fulltime smoking and
abandonment of the quit). Therefore, we propose a two-
month grace period during which lapses to smoking do
not count against achieving abstinence. As participants
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to the primary outcome being prolonged abstinence
from three months after quit day to 12 months follow
up. Following the Russell Standard, the primary outcome
will be prolonged abstinence from months four to 12
with no more than five lapses, confirmed by CO< 10
ppm at the 12-month assessment. The secondary out-
comes will be seven-day self-report point prevalence ab-
stinence at three months and seven-day biochemically
confirmed point prevalence abstinence at 12 months.
To assess cost-effectiveness, costs will be estimated
from a health service perspective. We will collect data
on the resource use associated with self-help materials
(including intellectual property, adaptation, printing and
postage), any additional stop smoking services and ces-
sation products at follow-up interviews. Our hypothesis
is that the intervention, if effective, will improve abstin-
ence rates, reduce repeated use of stop smoking services
and might reduce use of other health care. Other
resources which might be affected by the intervention
will also be monitored, including GP visits and hospital
admissions. The EQ-5D [34] will be used to estimate the
benefits in terms of the QALY gain associated with each
intervention during the study period.
At three months after quit day (two months after enroll-
ment), a researcher from UEA will telephone participants
primarily to assess process measures, that is, receipt, liking
of, and use of the manuals (in the intervention group) and
to assess key skills the manuals try to teach (in both the
intervention and control groups). If the intervention is in-
effective, this will help us to explain whether the interven-
tion was used but people did not acquire the skills or
whether applying the skills was ineffective in preventing
relapse. This early follow-up contact is important, consid-
ering the high risk of relapse during the first few months.
The second and final follow up telephone call (con-
ducted by a researcher from UEA) will take place at 12
months after quit day (11 months after enrollment), pri-
marily to assess the primary and secondary outcomes,
although we will once again test for skills acquired. Par-
ticipants who meet the self-report criteria for at least
seven-day abstinence will be invited to attend a local
center to prove this by exhaled CO. People may come to
a clinic at UEA or we can visit them at home for this
test. We will offer a shopping voucher (£20) to each of
the participants who have attended the CO-test at 12
months.
To minimize loss of follow-up, we will include the al-
ternative contact telephone for each trial participant and
ask the most appropriate time for the telephone contact.
If necessary, we will make multiple attempts to contact
trial participants. We will send the follow-up question-
naire by post with a freepost return envelope to those
we are not able to contact by telephone.Data analysis plan
We will develop a trial database to maintain data from
baseline and follow-up questionnaires. Data analyses will
be conducted using STATA software. The comparison of
smoking abstinence rates (and any other binary out-
comes) between the two trial arms will be carried out
using OR (and 95% confidence intervals) as the outcome
statistic.
The primary outcome will be prolonged abstinence
from months four to 12 with no more than five lapses,
confirmed by CO< 10 ppm at the 12-month assessment.
Participants who decline biochemical verification or who
do not respond to follow up will be counted as smokers
but those who have died or genuinely moved away will
be disregarded from the numerator and denominator. If
we detect differences in missing data we will assess the
robustness of our primary analyses by using imputation
methods such as pattern-mixture models [35].
Exploratory subgroup analyses, including logistic re-
gression analyses with interaction terms, will be con-
ducted to investigate possible effect-modifying variables,
including age, gender, socio-economic status, level of
nicotine dependence, number of prior quit attempts, and
use of pharmacological interventions. These exploratory
analyses have low statistical power and are also likely to
yield false positive findings so the results will need to be
interpreted with great caution.
The analysis of mediating variables will examine
hypothesized mechanisms of the intervention. The inter-
vention using the Forever Free booklets teaches skills
based on the cognitive-behavioral approach. The effect-
iveness of coping skills training for relapse prevention
depends on (1) the adequate delivery and receipt of the
booklets, (2) the acquisition of coping skills by quitters
and (3) the application of such skills in high-risk situa-
tions. This intervention mechanism suggests certain im-
portant process variables that should be investigated in
the trial. At the follow-up interviews, we will at first ask
trial participants whether they have received the book-
lets, whether they have read the booklets (and how
much time spent and how many booklets they looked
at). We will then investigate whether the use of booklets
helped in the acquisition of coping skills by the partici-
pants, in terms of improved capability to identify risky
situations and to know more appropriate ways of hand-
ling urges to smoke again. Thirdly, we will ask the trial
participants whether they have actually applied the skills
learned from the booklets. Finally, we will invite the trial
participants to give an overall assessment of the useful-
ness of the booklets. We will summarize data collected
in tables and plots to examine associations between
smoking abstinence and important mediating variables
(for example, level of the use of booklets, actual applica-
tion of coping skills in high-risk situations).
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ploratory mediation analysis according to MacKinnon
and Fairchild [36]. As an example, the Single-Mediator
model consists of three equations:
Y ¼ i1þ cXþ e1; ð1Þ
Y ¼ i2þ c0Xþ bMþ e2; ð2Þ
M ¼ i3þ aXþ e3; ð3Þ
where Y is the dependent variable (smoking relapse), X
is the independent variable (the intervention), and M is
the mediating variable (for example, time spent on read-
ing the booklets, acquisition of coping skills, and so on).
Then, the mediating effect of M could be quantified by
a*b (or c'-c). These exploratory mediation analyses will
help understand how and why the intervention works or
does not work.
Using data on time to the first event of smoking re-
lapse, survival curves of the intervention and control
arm will be compared by using Cox regression analysis
as secondary analyses. This might reveal patterns indi-
cating that relapse is postponed, which could suggest
that ‘top up interventions’ might be helpful.
Using data from the trial, we will calculate the mean
incremental cost for those in the intervention arm
(Forever Free booklets) compared to the control arm.
Similarly, the incremental effect of the intervention will be
equivalent to the difference in the 12-month quit rate be-
tween the two arms. If dominance does not occur (that is,
if one intervention is more costly and more effective) [37],
the incremental cost and incremental effect will be used
to calculate the cost required to have one more long-term
quitter with the provision of the Forever Free booklets.
The cost-effectiveness analysis will be based on individual
level costs and outcome data, with uncertainty expressed
as cost effectiveness acceptability curves and if appropri-
ate, CIs for the incremental cost effectiveness ratio. As
part of a cost-utility analysis, the incremental QALY gain
associated with the intervention will be estimated, based
on EQ-5D data collected in the trial and findings from
existing studies of relevant economic evaluations [38-40].
Ethical arrangements
No adverse effects or harm on the target population or
society could be expected from the intervention. We will
provide sufficient information for four-week quitters to
consider whether they would like to participate in the
trial and recruit only those who sign the consent form.
Data on individual participants will remain strictly confi-
dential. Only researchers directly involved in the trial
will have access to participants' personal data during thestudy. Research ethical approval has been granted by
East of England Research Ethics Committee (11/EE/
0091).
Project management
A Trial Steering Committee will be established to pro-
vide overall supervision for the study on behalf of the
National Institute for Health Research - Health Technol-
ogy Assessment (NIHR HTA) program. The trial will be
overseen by a trial management group (TMG), based at
UEA, including all co-investigators. The TMG will meet
every three months to monitor and manage the trial and
review an ongoing CONSORT statement (including data
on recruitment, intervention and follow-up). The Trial
Project Team, consisting of the trial coordinator/RA,
project secretary, and chief investigator, will meet at
UEA weekly to monitor the day-to-day progress and
management of the trial.
No adverse effects are expected to be associated with
the educational booklets for smoking relapse prevention.
This trial poses no substantial risks to participants and
there would be no cause to propose stopping rules for
premature closure of the trials. In addition, this trial is
open, un-blinded. After a discussion with the NIHR
HTA program, we decided not to have a separate Data
Monitoring Committee (DMC). Data monitoring will be
carried out by study team members (TMG) and be syn-
chronized with Trial Steering Committee meetings.
Project timetable and milestones
The proposed trial will last 36 months, including the re-
vising and printing of relapse prevention booklets, pa-
tient recruitment, delivery of interventions, follow-up
data collection, data analysis, and writing up report and
papers. The proposed trial start date is 1 June 2011. We
will need two months to revise and print the Forever
Free booklets and to arrange trainings for stop smoking
advisors who will be involved in the recruitment of four-
week quitters. The recruitment of trial participants will
start in August 2011 and last for 21 months until April
2013. This arrangement will cover the period in which
quit attempts are most frequent (January to March) in
both 2012 and 2013.
Discussion
Important public health implications
If proven effective, the use of the self-help booklets for
smoking relapse prevention may result in more than
7,000 additional long-term quitters each year in England,
which could be associated with 3,500 life-years saved
[19]. In addition, the self-help educational material for
smoking relapse prevention may be a cost-saving inter-
vention by reducing repeat use of the NHS Stop Smok-
ing Service and by reducing use of healthcare services
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relapse in four-week quitters may contribute to a reduc-
tion in adult smoking rates from 21% in 2008 to 10% or
less by 2020, a target set out in the new Tobacco
Control Strategy for England [41].
Major limitations of the study
Given the nature of interventions and methods for fol-
lowing up, it is impossible to confidently blind trial par-
ticipants and outcome assessors. However, the primary
outcome (CO-verified smoking abstinence at 12 months)
is objectively measured, which may be less vulnerable
than subjectively measured outcomes to bias due to lack
of blinding [28].
We will conduct exploratory analyses to investigate
factors associated with the effectiveness of self-help ma-
terial for the prevention of smoking relapse. The study
will investigate whether the use of the booklets helps the
acquisition of coping skills and whether the skills
learned have been applied when required. However,
questions asked at the follow-up interviews at three and
12 months may not be sufficient for the purpose of
process evaluations. Further qualitative research is
required to provide more details on patient experience
of the use of self-help educational materials for the pre-
vention of smoking relapse.
Trial status
Participant recruitment started in August 2011 and is
expected to end in April 2013.Abbreviations
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